0 NASDAQ Companies - November 27, 2018MYnd Analytics Awarded Subcontract to Support Suicide Prevention for the U.S. Department of Health and Human ServicesMISSION VIEJO, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) — MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the […]Read More
0 TSX News - November 27, 2018Empire Life adds Best Doctors services to group plansExpert medical review and healthcare navigation services KINGSTON, Ontario, Nov. 27, 2018 (GLOBE NEWSWIRE) — The Empire Life Insurance Company […]Read More
0 TSX Venture News - November 27, 2018IntelGenx Begins Montelukast VersaFilm™ Dosing in Patients with Mild to Moderate Alzheimer’s Disease in Phase 2a StudySAINT LAURENT, Quebec, Nov. 27, 2018 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today […]Read More
0 TSX Venture News - November 27, 2018Naturally Splendid Secures National Distribution for Pawsitive FX™ Pet Product LineVANCOUVER, British Columbia, Nov. 27, 2018 (GLOBE NEWSWIRE) — Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE” or “The Company”) […]Read More
0 TSX Venture News - November 27, 2018Pediapharm Announces Q2 Results – Record Adjusted EBITDA, Record Revenue and 13th Consecutive Year-Over-Year Quarterly Revenue GrowthNOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS […]Read More
0 TSX Venture News - November 27, 2018Avricore Health Signs Letter of Intent to Partner with FoodRocket to Enhance the HealthTab PlatformVANCOUVER, British Columbia, Nov. 27, 2018 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is pleased to announce […]Read More
0 TSX Venture News - November 27, 2018Cartier Cuts 6.6 g/t Au over 13.0 m Along Depth Extension of Zone 6N1 Doubling Resource Potential Near Mine InfrastructureHighlights: 23.3 g/t Au over 2.0 m included within 6.6 g/t Au over 13.0 m and 7.8 g/t Au over […]Read More
0 TSX Venture News - November 27, 2018Gowest Announces Private PlacementNot for distribution to United States newswire services or for dissemination in the United States TORONTO, Nov. 27, 2018 (GLOBE […]Read More
0 NASDAQ Companies - November 27, 2018Cytokinetics Completes Enrollment in FORTITUDE-ALS, Phase 2 Clinical Trial of Reldesemtiv in Patients With ALSClinical Trial Results Expected First Half 2019 SOUTH SAN FRANCISCO, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: […]Read More
0 NASDAQ Companies - November 27, 2018New Data Show EXPAREL Plays a Key Role in Achieving Significant Reductions in Opioid Use, Hospital Stay and Total Hospitalization Costs Following Painful Knee Replacement SurgeryResults show improved clinical and economic outcomes across 10 U.S. hospitals with highest EXPAREL utilization for total knee arthroplasties PARSIPPANY, […]Read More